Cannabis Suisse Corp. (CSUI)
Cannabis Suisse Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Jacksonville, FL, US. The stock last traded at $0.00, down 16.95% on the session, giving a market capitalisation of $346,337. On trailing twelve-month figures it carries a trailing P/E of 3.27, a net margin of 0.0%. Its beta of -3.80 implies it has historically moved less than the broad market.
Cannabis Suisse Corp., based in Bell Gardens, California, specializes in the cultivation, production, and distribution of a diverse range of products. These offerings include recreational tobacco goods, medical CBD oils, and various over-the-counter items such as health-related supplements, face masks, disinfectants, and cigarettes. The company makes its products available to consumers through its dedicated online retail platform, Swiss4Life, as well as via a broader network of retailers. Established in 2016, the firm initially traded as Geant Corp. before officially adopting its current name, Cannabis Suisse Corp., in February 2019.
Cannabis Suisse Corp. is most often compared with the following Healthcare names: